These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22914445)

  • 1. Effect of Patent Blue V(®) dye on sample interference indices on the Abbott Architect.
    McTaggart MP; Cannon LP; Kearney EM
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):510-1. PubMed ID: 22914445
    [No Abstract]   [Full Text] [Related]  

  • 2. Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V.
    Darby D; Broomhead C
    Ann Clin Biochem; 2008 May; 45(Pt 3):289-92. PubMed ID: 18482917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of patent blue V on pulse oximetry and haemoximetry.
    Larsen VH; Freudendal-Pedersen A; Fogh-Andersen N
    Acta Anaesthesiol Scand Suppl; 1995; 107():53-5. PubMed ID: 8599298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of patent blue dye with pulse oximetry readings, methemoglobin measurements, and blue urine in sentinel lymph node mapping: a case report and review of the literature.
    Lai HC; Hsu HM; Cherng CH; Lin SL; Wu CT; Yu JC; Yeh CC
    Acta Anaesthesiol Taiwan; 2011 Dec; 49(4):162-4. PubMed ID: 22221691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged interference of blue dye "patent blue" with pulse oximetry readings.
    Saito S; Fukura H; Shimada H; Fujita T
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):268-9. PubMed ID: 7793197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pulse oximetry after patent blue dye injection into the uterine cervix.
    Vieira SC; Sousa RB; Tavares MB; de Abreu BA; Ibiapina JO; de Sousa Oliveira AK; Zeferino LC
    Ann Surg Oncol; 2008 Oct; 15(10):2862-6. PubMed ID: 18696155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent blue sentinel node mapping in cervical cancer patients may lead to decreased pulse oximeter readings and positive methaemoglobin results.
    Kieckbusch H; Coldewey SM; Hollenhorst J; Haeseler G; Hillemanns P; Hertel H
    Eur J Anaesthesiol; 2008 May; 25(5):365-8. PubMed ID: 18272013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spectrophotometric determination of chondroitin sulfate with victory blue B].
    Chen YY; Jiang ZL; Li ZZ; Zhou SM; Sun SJ
    Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Jun; 26(6):1148-50. PubMed ID: 16961254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coomassie-Brilliant Blue staining of polyacrylamide gels.
    Arndt C; Koristka S; Feldmann A; Bartsch H; Bachmann M
    Methods Mol Biol; 2012; 869():465-9. PubMed ID: 22585511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method to improve dye application to the retinal surface during vitrectomy.
    Schmid MK
    Retina; 2011 Apr; 31(4):801-3. PubMed ID: 21386756
    [No Abstract]   [Full Text] [Related]  

  • 11. Quirks of dye nomenclature. 4. Fuchsine: four shades of magenta.
    Cooksey CJ; Dronsfield AT
    Biotech Histochem; 2015 May; 90(4):288-93. PubMed ID: 25555311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [False low oximetry reading caused by patent blue vital dye during breast surgery].
    Nasif LA; Campos JM; Piñol S; Delgado MO; Casas JI; Landeira JM
    Rev Esp Anestesiol Reanim; 2005 Mar; 52(3):169-71. PubMed ID: 15850305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green plasma.
    Berglund D; Lindvall P; Lubenow N
    Transfusion; 2015 Feb; 55(2):245. PubMed ID: 25683187
    [No Abstract]   [Full Text] [Related]  

  • 14. Coomassie stains: are they really mass spectrometry compatible?
    Sumpton D; Bienvenut W
    Rapid Commun Mass Spectrom; 2009 May; 23(10):1525-9. PubMed ID: 19370711
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and optical properties of mesoporous β-Co(OH)(2) /brilliant blue G (G250) hybrid hierarchical structures.
    Cong HP; Ren XC; Yao HB; Wang P; Cölfen H; Yu SH
    Adv Mater; 2012 Mar; 24(10):1309-15. PubMed ID: 22298193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nomenclature and Identification Method of Non-Permitted Dyes of Patent Blue Group].
    Shinya M; Ki M; Yamaguchi Y
    Shokuhin Eiseigaku Zasshi; 2020; 61(2):58-62. PubMed ID: 32336710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of prolonged reduction in arterial oxygen saturation measured by pulse oxymetry after administering patent blue in an elderly patient].
    Takahashi Y; Hara K; Sata T
    Masui; 2013 Apr; 62(4):442-4. PubMed ID: 23697198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients blue on patent blue: an adverse reaction during four sentinel node procedures.
    Beenen E; de Roy van Zuidewijn DB
    Surg Oncol; 2005 Dec; 14(4):151-4. PubMed ID: 16473001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native immunoblotting of blue native gels to identify conformation-specific antibodies.
    Zickermann V; Wumaier Z; Wrzesniewska B; Hunte C; Schägger H
    Proteomics; 2010 Jan; 10(1):159-63. PubMed ID: 19882660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photocatalytic decouloration of malachite green dye by application of TiO2 nanotubes.
    Prado AG; Costa LL
    J Hazard Mater; 2009 Sep; 169(1-3):297-301. PubMed ID: 19443110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.